CWWeekly March 10th 2008 Issue

Friday, March 14, 2008 10:30 AM

Top News

 

AbCRO Opens Two Offices in Russia

Sofia, Bulgaria-based, American-owned contract research organization AbCRO opened two offices in Russia. AbCRO currently has 170 employees. AbCRO also has offices in Bucharest and Cluj, Romania; Zagreb, Croatia; and Belgrade, Serbia. In addition, the company opened an office in Warsaw, Poland, last year.

PRA Doubles Kansas Phase I Unit

Raleigh, N.C.-based contract research organization (CRO) PRA International has opened a new clinical pharmacology unit (CPU), adding about 40 beds in Lenexa, Kansas.The facility replaces a smaller nearby phase I unit and doubled PRA’s presence in the area to 80 beds. The 16,000-square-foot facility was built at a cost of about $2 million. According to Tamminga, the new CPU in Kansas will focus on “high-end” complex trials that require a lot of skill and knowledge to perform.

Other breaking news...

  • GRS launches phase I data management platform...
  • Georgia Institute of Technology develops drug compliance device “necklace”...

Company Profile: An interview with Ron Waife, president, Waife & Associates

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs